1. Home
  2. NCEL vs EVOK Comparison

NCEL vs EVOK Comparison

Compare NCEL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.75

Market Cap

18.3M

Sector

Health Care

ML Signal

N/A

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.84

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCEL
EVOK
Founded
2008
2007
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
18.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NCEL
EVOK
Price
$3.75
$10.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
147.3K
246.6K
Earning Date
12-01-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,424,652.00
Revenue This Year
N/A
$57.38
Revenue Next Year
N/A
$59.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.40
52 Week Low
$3.06
$1.94
52 Week High
$7.64
$10.90

Technical Indicators

Market Signals
Indicator
NCEL
EVOK
Relative Strength Index (RSI) N/A 84.87
Support Level N/A $10.66
Resistance Level N/A $10.75
Average True Range (ATR) 0.00 0.06
MACD 0.00 -0.13
Stochastic Oscillator 0.00 96.15

Price Performance

Historical Comparison
NCEL
EVOK

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: